Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis

[1]  C. Botta,et al.  Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis , 2014, Molecular Cytogenetics.

[2]  A. Sapino,et al.  Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues , 2013, Front. Oncol..

[3]  R. Maestro,et al.  Mesenchymal traits are selected along with stem features in breast cancer cells grown as mammospheres , 2012, Cell cycle.

[4]  A. Tutt,et al.  Molecular characterisation of cell line models for triple-negative breast cancers , 2012, BMC Genomics.

[5]  Jia Luo,et al.  Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells. , 2012, Cancer research.

[6]  Sheng-Xiang Lin,et al.  Correction: Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7 , 2012, PLoS ONE.

[7]  R. Gelber,et al.  Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  G. Sozzi,et al.  Molecular cytogenetic characterization of stem-like cancer cells isolated from established cell lines. , 2010, Cancer letters.

[9]  M. Hung,et al.  The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines , 2010, Breast cancer : basic and clinical research.

[10]  A. Ashworth,et al.  Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray‐based CGH analysis , 2009, The Journal of pathology.

[11]  John D. Minna,et al.  Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery , 2009, PloS one.

[12]  Johan Staaf,et al.  High‐resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization , 2007, Genes, chromosomes & cancer.

[13]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[14]  W. Lam,et al.  Comprehensive copy number profiles of breast cancer cell model genomes , 2006, Breast Cancer Research.

[15]  M. Lacroix,et al.  Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.

[16]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[17]  Joseph Geradts,et al.  Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues. , 2002, The American journal of pathology.

[18]  M. Hung,et al.  Her2/neu induces all-transretinoic acid (ATRA) resistance in breast cancer cells , 2002, Oncogene.

[19]  H. Moch,et al.  DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[21]  A. Bowcock,et al.  Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. , 2001, Cancer research.

[22]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C Caldas,et al.  Molecular cytogenetic analysis of breast cancer cell lines , 2000, British Journal of Cancer.

[24]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[25]  C. Larsson,et al.  Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping , 2000, Genes, chromosomes & cancer.

[26]  S. Sen,et al.  Aneuploidy and cancer , 2000, Current opinion in oncology.

[27]  S. Baatout.  Molecular basis to understand polyploidy. , 1999, Hematology and cell therapy.

[28]  B. Williams,et al.  Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. , 1998, Human molecular genetics.

[29]  K. Hirata,et al.  Frequency of chromosome 7 gain in human breast cancer cells: correlation with the number of metastatic lymph nodes and prognosis. , 1998, The Tohoku journal of experimental medicine.

[30]  J. Gudmundsson,et al.  Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. , 1995, British Journal of Cancer.

[31]  G. Hampton,et al.  Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. , 1995, Cancer research.

[32]  L. Cherbas,et al.  Cell Lines , 1992, Methods.

[33]  C. Osborne,et al.  Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu , 1992, Breast Cancer Research and Treatment.

[34]  L A Rogers,et al.  The American Type Culture Collection , 1925, Nature.

[35]  L. A. Rogers.  THE AMERICAN TYPE-CULTURE COLLECTION. , 1925, Science.

[36]  L. Shaffer,et al.  ISCN 2009 - An International System for Human Cytogenetic Nomenclature , 2009 .

[37]  P. Edwards,et al.  Evaluation of 24-color Multifluor-Fluorescence In-situ Hybridization (M-FISH) Karyotyping by Comparison with Reverse Chromosome Painting of the Human Breast Cancer Cell Line T-47D , 2004, Chromosome Research.

[38]  L. Kearney.  Molecular cytogenetics. , 2001, Best practice & research. Clinical haematology.

[39]  平田 恵三.  Frequency of chromosome 7 gain in human breast cancer cells : correlation with the number of metastatic lymph nodes and prognosis , 1998 .